Skip to main content
. 2015 Jul 6;10(7):e0131566. doi: 10.1371/journal.pone.0131566

Table 2. Reasons for treatment failure.

carbamazepine valproate lamotrigine topiramate oxcarbazepine
N 125 151 135 76 167
Adverse events 32(25.6) 36(23.8) 15(11.1) 20(26.3) 23(13.8)
Lack of efficacy 29(23.2) 49(32.5) 30(22.2) 20(26.3) 45(26.9)
Others a 8(6.4) 7(4.6) 4(3.0) 1(1.3) 11(6.6)

aOthers: other reasons including pregnancy, poor economic conditions, non-compliance (discontinuation of AEDs by themselves with a single discontinuation time of ≥ two weeks), deaths related to seizures